Dissolution enhancement of Gefitinib by solid dispersion and complexation with β-cyclodextrins: In vitro testing, cytotoxic activity, and tablet formulation

Adel F. Alghaith; Gamal M. Mahrous; Ahmed S. Alenazi; Suliaman M. ALMufarrij; Mohammed S. Alhazzaa; Awwad A. Radwan; Abdullah S. Alhamed; Mohamed S. Bin Salamah; Sultan Alshehri

doi:10.1016/j.jsps.2024.102070

Q1 2024

Dissolution enhancement of Gefitinib by solid dispersion and complexation with β-cyclodextrins: In vitro testing, cytotoxic activity, and tablet formulation

Adel F. Alghaith · Gamal M. Mahrous · Ahmed S. Alenazi · Suliaman M. ALMufarrij · Mohammed S. Alhazzaa · Awwad A. Radwan · Abdullah S. Alhamed · Mohamed S. Bin Salamah · Sultan Alshehri

10.1016/j.jsps.2024.102070 394 المشاهدات 4 الاقتباسات

الاقتباسات

394

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Adel, F. A., Gamal, M. M., Ahmed, S. A., Suliaman, M. A., Mohammed, S. A., Awwad, A. R., Abdullah, S. A., Mohamed, S. B. S., Sultan, A. (2024). Dissolution enhancement of Gefitinib by solid dispersion and complexation with β-cyclodextrins: In vitro testing, cytotoxic activity, and tablet formulation. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.102070

Rabia Gul; Hamid Bashir; Muhammad Sarfraz; Ahson Jabbar Shaikh; Yousef A. Bin Ja · 2024

استشهاد

395

Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems

Kampanart Huanbutta; Vivek Puri; Ameya Sharma; Inderbir Singh; Pornsak Sriamorns · 2024

استشهاد

391

A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities

Hussain A. Al-Omar; Ali Alshehri; Saleh A. Alqahtani; Hana Alabdulkarim; Ali Alr · 2024

استشهاد

394

Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management …